Thursday, September 29, 2022

China issues subtle pharma APIs export ban threat to India in retaliation

Centre readying PLLI scheme for boosting domestic production of APIs and intermediates

New Delhi: China has started issuing veiled threats to India about a possible sanction on exports of APIs which are crucial middle products for Indian medicine industry. The veiled threat comes with a terse message that this is a clear sign that the world’s fifth largest economy could ill-afford a trade war with China.

Global Times, which is widely regarded as the mouthpiece of CCP, today said in a tweet: “Days after implementing a ban on Chinese imports at customs, India is reportedly starting to clear APIs, vital middle products for its medicine industry. Experts said this is a clear sign that the world’s fifth economy could ill-afford a trade war with China.”

This threat comes in the wake of banning of 59 China based apps by Indian government.

Indian Pharma industry has been dependent on sourcing of APIs, the middle products for so many molecules, from China.

According to Pharma companies,, the supplies from China have been continuing so far without any problems, but with trade tensions rising and the ban on 59 Chinese apps, there is a possibility that China may also retaliate by curbing exports of APIs. This may hurt the Indian Pharma industry in the days to come.

However, Indian government has been aware of this dependence of Pharma industry on supplies of APIs from China. This is the reason the Centre is trying to fast-track launch of a PLI scheme to promote local manufacturing of active pharmaceutical ingredients (APIS).

For now, India imports around 80% of its APIs and starting ingredients for drugs from China. And the reason is that imports from China are very cost-effective.

But Indian government is now trying to do away with this dependence on supplies from China.

In a recent notification, the Department of Pharmaceuticals (DoP) had rolled out draft guidelines for the proposedPLI scheme. The guidelines were recommended by a technical committee, headed by Joint Drugs Controller S Eswara Reddy.

The committee made a recommendation to set up a Drug Security Authority (DSA) under the DoP, which is overseen by the Ministry of Chemicals and Fertilizers.

The aim of DSA will be to make India self-dependent in pharma sector and to help it create a supply chain of APIs and key starting materials for the pharma indsutry.

ALSO READ

Piyush Goyal reviews progress of Government e-Marketplace

0
Piyush Goyal asks GeM to improve monitoring of delivery against timelines, calls for strong legal and punitive actions against fraudulent activities on the portal New...
Mooduvudu – Mooduvudu, Navabharatda leele

Mooduvudu – Mooduvudu, Navabharatda leele

0
President Droupadi Murmu quotes Kannada poet Kuvempu, saying: On our bones will arise the great tale of a new India Desk: Droupadi Murmu, the President...

OPINION

MGM College & Hospital needs Govt attention!

0
The condition of MGM College & Hospital needs urgent attention of the state government, especially the Health Minister Banna Gupta himself. Being a referral hospital,...
Town Post Edit

India must stop Hindu genocide in Pakistan and Bangladesh

0
It took a former Congressional candidate Manga Anantmula, the mother of a US Navy commander to call out Pakistan’s systematic cruelty against minority women....

TRENDING NOW

The greatness of our MOTHERLAND

0
Swami Vivekananda If there is any land on this earth that can lay claim to be the blessed Punyabhumi (holy land), to be the land...
Aug. 11, 2022 Croma launch7 (1)

Bistupur gets 1st Croma store of Jamshedpur, 2nd in Jharkhand

0
Expansive Electronics retail destination now open opposite Gopal maidan at Bistupur, Jamshedpur Jamshedpur: Croma, India’s first and trusted Omnichannel electronics retailer from the Tata Group,...

Feel like reacting? Express your views here!

Read More

Comments

Recent

Subsribe Our Newsletter & get Free Daily News & Opinion updates!

Town Post

FREE
VIEW